Phylos is an Oregon-based cannabis genetics company that manufactures and markets cannabis and hemp seeds for commercial growers.
$1M
Jul 23, 2024
-
Sanity Group is a Germany-based holding firm that owns and operates cannabis brands that develop cannabinoid-based medicines and consumer products for the healthcare sector.
$15M
Jun 24, 2024
-
OBX is a North Carolina-based cannabis company that manufactures and supplies hemp-based cannabinoid products for the commercial market.
$2M
Mar 25, 2024
-
Greentank is a Canada-based B2B technology company that develops and manufactures precision-made vaporization hardware products for the cannabis industry.
$16.5M
Mar 30, 2023
-
Hyasynth Bio is a biotechnology company that develops and commercializes cannabinoids for the healthcare industry.
$2.5M
Oct 22, 2020
-
Frequently Asked Questions about Organigram
What is Organigram investing in?
Organigram has invested in 6 companies including Phylos, Sanity Group and OBX
What company did Organigram invest in?
Organigram invested in a total 6 companies including Phylos, Sanity Group and OBX
What are the top 5 investments by Organigram?
The top companies in which Organigram invested are Phylos, Sanity Group, OBX, Greentank and Hyasynth Bio
